To determine, in areas supported by BRAC, Bangladesh i) the pre-diagnosis and pre-treatment attrition among presumptive and confirmed Multi-Drug Resistant Tuberculosis (MDR-TB) patients and ii) factors associated with attrition.This was a retrospective cohort study involving record review. Presumptive MDR-TB patients from peripheral microscopy centres serving 60% of the total population of Bangladesh were included in the study. Attrition and turnaround time for MDR-TB diagnosis by Xpert MTB/RIF and treatment initiation were calculated between July 2012 and June 2014.Of 836 presumptive MDR-TB patients referred from 398 peripheral microscopy centres, 161 MDR-TB patients were diagnosed. The number of diagnosed MDR-TB patients was less than cou...
The aim of this study is to assess the determinants of multi-drug resistant tuberculosis patients (M...
Context: Treatment of multidrug resistant tuberculosis (MDR-TB) is challenging. In India, standard t...
Multidrug-resistant tuberculosis (MDR-TB) is an increasing global problem, with most cases arising f...
To determine, in areas supported by BRAC, Bangladesh i) the pre-diagnosis and pre-treatment attritio...
Objective. Previous tuberculosis (TB) treatment status is an established risk factor for multidrug-r...
Abstract Background Pre-diagnosis attrition needs to be addressed urgently if we are to make progres...
Objective: Previous tuberculosis (TB) treatment status is an established risk factor for multidrug-r...
Research Doctorate - Doctor of Philosophy (PhD)Background: Bangladesh is one of the high burden coun...
BackgroundChina's national tuberculosis programme does not have cohort wise information regarding at...
SETTING: Individualised regimens based on drug susceptibility test results, generally used to treat ...
To determine the risk factors for developing multidrug resistant tuberculosis in Bangladesh.This cas...
Tuberculosis [TB] remains one of the biggest health problems in developing and industrialized countr...
Revised National TB Control Programme (RNTCP), Andhra Pradesh, India. There is limited information o...
Background: This study was carried out to determine the characteristics of MDR-TB cases under treatm...
Abstract Background Interim treatment outcomes at 6-months for multidrug-resistant tuberculosis (MDR...
The aim of this study is to assess the determinants of multi-drug resistant tuberculosis patients (M...
Context: Treatment of multidrug resistant tuberculosis (MDR-TB) is challenging. In India, standard t...
Multidrug-resistant tuberculosis (MDR-TB) is an increasing global problem, with most cases arising f...
To determine, in areas supported by BRAC, Bangladesh i) the pre-diagnosis and pre-treatment attritio...
Objective. Previous tuberculosis (TB) treatment status is an established risk factor for multidrug-r...
Abstract Background Pre-diagnosis attrition needs to be addressed urgently if we are to make progres...
Objective: Previous tuberculosis (TB) treatment status is an established risk factor for multidrug-r...
Research Doctorate - Doctor of Philosophy (PhD)Background: Bangladesh is one of the high burden coun...
BackgroundChina's national tuberculosis programme does not have cohort wise information regarding at...
SETTING: Individualised regimens based on drug susceptibility test results, generally used to treat ...
To determine the risk factors for developing multidrug resistant tuberculosis in Bangladesh.This cas...
Tuberculosis [TB] remains one of the biggest health problems in developing and industrialized countr...
Revised National TB Control Programme (RNTCP), Andhra Pradesh, India. There is limited information o...
Background: This study was carried out to determine the characteristics of MDR-TB cases under treatm...
Abstract Background Interim treatment outcomes at 6-months for multidrug-resistant tuberculosis (MDR...
The aim of this study is to assess the determinants of multi-drug resistant tuberculosis patients (M...
Context: Treatment of multidrug resistant tuberculosis (MDR-TB) is challenging. In India, standard t...
Multidrug-resistant tuberculosis (MDR-TB) is an increasing global problem, with most cases arising f...